Position in ANIK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$154,668
-$51,522 QoQ
Shares Held
10,572
-25.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 134 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $48,172,745 across 31 Drug Manufacturers - Specialty & Generic names. ANIK ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
419,136 | $6,655,879 | |
| 2 | ZTS |
Zoetis Inc.
|
81,282 | $5,840,924 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,944 | $4,846,127 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
26,150 | $4,407,321 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
120,099 | $4,163,832 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
122,056 | $3,003,798 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,581 | $2,899,484 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
152,601 | $2,446,194 |
All Filings in ANIK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,668 | 10,572 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $206,190 | 14,220 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $158,132 | 16,455 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $197,964 | 21,060 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $206,405 | 19,509 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $151,833 | 10,102 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||